Literature DB >> 17594920

In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004).

M I Garcia Garcia1, J L Munoz Bellido, J A Garcia Rodriguez.   

Abstract

The susceptibility patterns of 2724 uropathogens isolated in 9 Spanish regions during 2002, and 3013 obtained in 2004 were determined. The antibiotics tested were fosfomycin trometamol, amoxicillin, co-amoxiclav, cefixime, cefuroxime-axetil, pipemidic, ceprofloxacin, trimethoprim plus sulphamethoxazole and nitrofurantoin. Escherichia coli was the main pathogen in both studies (73% vs. 68.3%) followed by Proteus mirabilis 7.2% vs. 6.4%) and Klebsiella pneumoniae (5.4% vs. 5.2%). Enteroccocus spp. (4.7% vs. 6.8%), Streptoccocus agalactiae (1.7% vs. 3.1%) and Staphyloccocus saprophyticus (0.7% vs. 1.3%)were the most frequent Gram-positive pathogens. 31.3% of E. coli in 2002 and 32% in 2004 were susceptible to all antibiotics tested. Around 40% of E. coli were resistant to a single agent. 21.6-24.1% were resistant to two antibiotics. 35.4% of first period isolates, and 37.6% of second period ones were resistant to two or more classes of antibiotics. Fosfomycin (2.1- 2.8%) and nitrofurantoin (3.5-5.7%) had the lowest resistance rates for E. coli. Amoxicillin (58.2-58.7%), co-trimoxazole (30.8-33.8%) and ciprofloxacin (22.6-22.7%) showed the highest resistance rates, and their suitability as empiric treatments for UTI should probably be re-evaluated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594920     DOI: 10.1179/joc.2007.19.3.263

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  10 in total

Review 1.  Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

3.  Pharmaceutical analysis of a novel propargyl-linked antifolate antibiotic in the mouse.

Authors:  John Hoody; Jeremy B Alverson; Santosh Keshipeddy; Patrick A Barney; Larissa Walker; Amy C Anderson; Dennis L Wright; Nigel D Priestley
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-03-06       Impact factor: 3.205

4.  Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates.

Authors:  Michael N Lombardo; Narendran G-Dayanandan; Dennis L Wright; Amy C Anderson
Journal:  ACS Infect Dis       Date:  2016-01-04       Impact factor: 5.084

Review 5.  Contemporary management of uncomplicated urinary tract infections.

Authors:  David R P Guay
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent urinary tract infections in childhood.

Authors:  Siiri Kõljalg; Kai Truusalu; Inga Vainumäe; Jelena Stsepetova; Epp Sepp; Marika Mikelsaar
Journal:  J Clin Microbiol       Date:  2008-10-29       Impact factor: 5.948

7.  Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity.

Authors:  Kristen M Lamb; Michael N Lombardo; Jeremy Alverson; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

8.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

9.  Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients.

Authors:  V Niranjan; A Malini
Journal:  Indian J Med Res       Date:  2014-06       Impact factor: 2.375

10.  Antimicrobial Resistance of Escherichia coli Causing Uncomplicated Urinary Tract Infections: A European Update for 2014 and Comparison with 2000 and 2008.

Authors:  Gunnar Kahlmeter; Jenny Åhman; Erika Matuschek
Journal:  Infect Dis Ther       Date:  2015-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.